Encompass Health CORP Form 4 insider transactions

Encompass Health's CFO, Douglas Coltharp, disposed of shares to cover tax obligations related to vesting restricted stock, while also reporting holdings in trusts and by his spouse.

Edmund Fay, Sr. Vice President and Treasurer of Encompass Health Corp, reported disposing of shares to cover tax withholding obligations related to vesting restricted stock.

Encompass Health's CEO, Mark Tarr, disposed of shares to cover tax obligations related to the vesting of restricted stock.

Andrew L. Price, Chief Accounting Officer of Encompass Health Corp, reports disposing of shares to cover tax withholding obligations related to vesting restricted stock.

Encompass Health's EVP & Chief Financial Officer, Douglas Coltharp, reports acquisition of restricted stock and dispositions, along with holdings in irrevocable trusts and spousal ownership.

Edmund Fay, Sr. Vice President and Treasurer of Encompass Health Corp, reports acquiring 1,404 shares of restricted stock on February 20, 2025, as part of an annual award.

John Patrick Darby, EVP, Gen Counsel & Secretary of Encompass Health Corp, reports the acquisition of 2,216 shares of common stock on February 20, 2025, through an annual restricted stock award.

Elissa Joy Charbonneau, Chief Medical Officer of Encompass Health Corp, reports acquiring 1,939 shares of common stock as part of an annual restricted stock award.

Andrew L. Price, Chief Accounting Officer of Encompass Health Corp, acquired 1,538 shares of company stock on February 20, 2025, as part of an annual restricted stock award.

Encompass Health Corp's CEO, Mark J. Tarr, acquired 12,152 shares of common stock on February 20, 2025, as part of an annual restricted stock award.

Andrew L. Price, Chief Accounting Officer of Encompass Health Corp, sold 5,042 shares of common stock at an average price of $98.29 on February 13, 2025.

Terrance Williams, a director at Encompass Health Corp, acquired 25 additional shares of common stock through a dividend reinvestment program.

Director Nancy M. Schlichting acquired 36 shares of Encompass Health Corp stock through a dividend reinvestment program.

Director Christopher R. Reidy of Encompass Health Corp. reports acquiring shares through dividend reinvestment and a deferred stock plan.

Director Kevin J. O'Connor received 14 shares of Encompass Health stock through a dividend reinvestment program.

Patricia Anne Maryland, a director at Encompass Health Corp, received 25 restricted stock units (RSUs) due to a dividend payment.

Director Leslye G. Katz acquired 83 shares of Encompass Health Corp through a dividend reinvestment program.

Director Joan E. Herman acquired 83 shares of Encompass Health Corp stock through a dividend reinvestment program.

Director Greg D. Carmichael acquired 25 additional shares of Encompass Health Corp through a dividend reinvestment program.

Director Edward M. Christie III increased his holdings in Encompass Health through dividend reinvestment and a deferred stock investment plan.

Elissa Charbonneau, Chief Medical Officer of Encompass Health Corp, reported a transaction involving the withholding of 2,991 shares of common stock to cover tax obligations.

Encompass Health's EVP and Chief Financial Officer, Douglas Coltharp, reported a transaction involving the withholding of 12,438 shares to cover tax obligations.

Encompass Health's EVP, General Counsel, and Secretary, John Patrick Darby, sold 5,917 shares of company stock to cover tax obligations related to vesting restricted stock.

Encompass Health CEO Mark Tarr sold 31,609 shares of company stock on January 1, 2025, to cover tax obligations related to vesting restricted stock.

Encompass Health's Senior Vice President and Treasurer, Edmund Fay, disposed of 2,291 shares of common stock to cover tax obligations related to vesting restricted stock.

Andrew L. Price, Chief Accounting Officer of Encompass Health Corp, sold 2,446 shares of company stock to cover tax obligations related to vesting restricted stock.

Encompass Health's EVP and Chief Financial Officer, Douglas E. Coltharp, gifted 65,229 shares of company stock to his spouse in a non-derivative transaction.

Terrance Williams, a director of Encompass Health Corp, acquired 24 shares of common stock through a dividend reinvestment program on October 15, 2024.

Director Christopher R. Reidy reports acquisitions of Encompass Health Corp stock through dividend reinvestment and participation in the Directors Deferred Stock Investment Plan.

Director Nancy M. Schlichting reports the acquisition of additional restricted stock units (RSUs) in Encompass Health Corp due to a dividend payment.